scholarly journals CT Demonstration of the 1996 AJCC-UICC Regional Lymph Node Classification for Lung Cancer Staging

Radiographics ◽  
1999 ◽  
Vol 19 (4) ◽  
pp. 899-899 ◽  
Author(s):  
Michel Cymbalista ◽  
Albert Waysberg ◽  
Claude Zacharias ◽  
Yves Ajavon ◽  
Marc Riquet ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Lymph Node ◽  
Regional Lymph Node ◽  
Cancer Staging ◽  
Node Classification

Regional Lymph Node Classification for Lung Cancer Staging

CHEST Journal ◽  
1997 ◽  
Vol 111 (6) ◽  
pp. 1718-1723 ◽  
Author(s):  
Clifton F. Mountain ◽  
Carolyn M. Dresler
Keyword(s):  
Lung Cancer ◽  
Lymph Node ◽  
Regional Lymph Node ◽  
Cancer Staging ◽  
Node Classification

scholarly journals Endobronchial ultrasound-guided transbronchial needle aspiration for lung cancer staging: early experience in Brazil,

2015 ◽  
Vol 41 (1) ◽  
pp. 23-30 ◽  
Author(s):  
Viviane Rossi Figueiredo ◽  
Paulo Francisco Guerreiro Cardoso ◽  
Márcia Jacomelli ◽  
Sérgio Eduardo Demarzo ◽  
Addy Lidvina Mejia Palomino ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Lymph Node ◽  
Lymph Nodes ◽  
Cancer Staging ◽  
Accurate Method ◽  
Needle Aspiration ◽  
Endobronchial Ultrasound ◽  
Lymph Node Staging ◽  
Ultrasound Guided ◽  
Transbronchial Needle Aspiration

Objective: Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is a minimally invasive, safe and accurate method for collecting samples from mediastinal and hilar lymph nodes. This study focused on the initial results obtained with EBUS-TBNA for lung cancer and lymph node staging at three teaching hospitals in Brazil. Methods: This was a retrospective analysis of patients diagnosed with lung cancer and submitted to EBUS-TBNA for mediastinal lymph node staging. The EBUS-TBNA procedures, which involved the use of an EBUS scope, an ultrasound processor, and a compatible, disposable 22 G needle, were performed while the patients were under general anesthesia. Results: Between January of 2011 and January of 2014, 149 patients underwent EBUS-TBNA for lymph node staging. The mean age was 66 ± 12 years, and 58% were male. A total of 407 lymph nodes were sampled by EBUS-TBNA. The most common types of lung neoplasm were adenocarcinoma (in 67%) and squamous cell carcinoma (in 24%). For lung cancer staging, EBUS-TBNA was found to have a sensitivity of 96%, a specificity of 100%, and a negative predictive value of 85%. Conclusions: We found EBUS-TBNA to be a safe and accurate method for lymph node staging in lung cancer patients.

Imaging of regional lymph node metastases with 99mTc-depreotide in patients with lung cancer

2005 ◽  
Vol 32 (8) ◽  
pp. 925-931 ◽  
Author(s):  
Rimma Danielsson ◽  
Margaretha Bååth ◽  
Leif Svensson ◽  
Ulrica Forslöv ◽  
Karl-Gustav Kölbeck
Keyword(s):  
Lung Cancer ◽  
Lymph Node ◽  
Lymph Node Metastases ◽  
Regional Lymph Node ◽  
Node Metastases

Metastatic Lung Cancer Without Regional Lymph Node Swelling

CHEST Journal ◽  
2001 ◽  
Vol 120 (2) ◽  
pp. 689-690 ◽  
Author(s):  
Hiroaki Satoh ◽  
Hiroichi Ishikawa ◽  
Yuko T. Yamashita ◽  
Morio Ohtsuka ◽  
Kiyohisa Sekizawa
Keyword(s):  
Lung Cancer ◽  
Lymph Node ◽  
Regional Lymph Node ◽  
Metastatic Lung Cancer ◽  
Metastatic Lung ◽  
Lymph Node Swelling

scholarly journals Image directed lymph node sampling for lung cancer staging

2014 ◽  
Vol 14 (S1) ◽  
Author(s):  
Leslie E Quint ◽  
Douglas Arenberg ◽  
Rishindra M Reddy ◽  
Jules Lin
Keyword(s):  
Lung Cancer ◽  
Lymph Node ◽  
Cancer Staging ◽  
Lymph Node Sampling

Lung Cancer: Staging

Chest Imaging ◽  
2019 ◽  
pp. 281-287
Author(s):  
Ryo E. C. Benson
Keyword(s):  
Lung Cancer ◽  
Lymph Node ◽  
Mediastinal Lymph Node ◽  
Tnm Classification ◽  
Cancer Staging ◽  
Tnm Staging ◽  
Small Cell ◽  
Small Cell Lung ◽  
Lung Cancers ◽  
Resected Tumor

Lung cancer staging is a process used to assess the extent of spread of lung cancer, determine the most appropriate treatment and predict the patient’s prognosis. Clinical staging is performed prior to surgical resection, while surgical-pathologic staging is based on histologic analysis of the resected tumor and lymph nodes. Restaging is performed following treatment. Staging is based on the TNM classification system. T refers to the primary tumor, N to thoracic lymph node involvement and M to metastatic disease. Recent changes to T and M descriptors were made to better reflect actual survival. For the majority of non-small cell lung cancers, the presence or absence of mediastinal lymph node spread is the most important outcome predictor. Although no changes were made to the N descriptor, the actual intrathoracic lymph node stations were recently clarified. Although the majority of small cell lung cancers are metastatic at the time of presentation, the presence of limited versus extensive spread of disease determines treatment options. However, the overall prognosis and survival for affected patients is poor. TNM staging is now recommended for carcinoid tumors as well as small cell lung cancer.

Validity of using lobe-specific regional lymph node stations to assist navigation during lymph node dissection in early stage non-small cell lung cancer patients

Surgery Today ◽  
2013 ◽  
Vol 44 (11) ◽  
pp. 2028-2036 ◽  
Author(s):  
Shinichiro Miyoshi ◽  
Kazuhiko Shien ◽  
Shinichi Toyooka ◽  
Kentaroh Miyoshi ◽  
Hiromasa Yamamoto ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Lymph Node ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Early Stage ◽  
Regional Lymph Node ◽  
Small Cell ◽  
Node Dissection ◽  
Small Cell Lung ◽  
Lung Cancer Patients
Sign in / Sign up

Export Citation Format

Share Document